§ Federal grant opportunity · HT942526LCRPPCOSA

    DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

    Danielle Reckley Grantor is accepting applications for DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award. The deadline is September 2, 2026 and the published award range is Award amount not published.

    Key facts

    Funder
    Danielle Reckley Grantor
    Application deadline
    September 2, 2026
    Award range
    Award amount not published
    Eligibility
    Eligibility criteria are published in the funding opportunity announcement.
    Geography
    United States
    Focus areas
    Research
    Opportunity number
    HT942526LCRPPCOSA

    Program overview

    Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category. Distinctive Features: • This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver. • This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

    How to apply

    1. Confirm your organization meets the eligibility criteria above.
    2. Read the full funding opportunity announcement from Danielle Reckley Grantor.
    3. Draft your narrative against the funder's stated priorities and review criteria.
    4. Submit before September 2, 2026, allowing time for registration and validation.

    View the official funding announcement

    Find every grant your organization qualifies for

    Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.